BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18540741)

  • 1. The effect of attributional processes concerning medication taking on return of fear.
    Powers MB; Smits JA; Whitley D; Bystritsky A; Telch MJ
    J Consult Clin Psychol; 2008 Jun; 76(3):478-90. PubMed ID: 18540741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
    Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
    J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the judicious use of safety behaviors improve the efficacy and acceptability of exposure therapy for claustrophobic fear?
    Deacon BJ; Sy JT; Lickel JJ; Nelson EA
    J Behav Ther Exp Psychiatry; 2010 Mar; 41(1):71-80. PubMed ID: 19892318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fear activation and distraction during the emotional processing of claustrophobic fear.
    Telch MJ; Valentiner DP; Ilai D; Young PR; Powers MB; Smits JA
    J Behav Ther Exp Psychiatry; 2004 Sep; 35(3):219-32. PubMed ID: 15262218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental demonstration that fear, but not disgust, is associated with return of fear in phobias.
    Edwards S; Salkovskis PM
    J Anxiety Disord; 2006; 20(1):58-71. PubMed ID: 16325114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and cognitive group treatment for fear of flying: a randomized controlled trial.
    Van Gerwen LJ; Spinhoven P; Van Dyck R
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):358-71. PubMed ID: 16828460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental reinstatement of context and return of fear in spider-fearful participants.
    Mystkowski JL; Craske MG; Echiverri AM; Labus JS
    Behav Ther; 2006 Mar; 37(1):49-60. PubMed ID: 16942960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to replicate the deleterious effects of safety behaviors in exposure therapy.
    Sy JT; Dixon LJ; Lickel JJ; Nelson EA; Deacon BJ
    Behav Res Ther; 2011 May; 49(5):305-14. PubMed ID: 21397895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.
    Wolitzky KB; Telch MJ
    Behav Ther; 2009 Mar; 40(1):57-71. PubMed ID: 19187817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
    Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
    Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive mechanisms of social anxiety reduction: an examination of specificity and temporality.
    Smits JA; Rosenfield D; McDonald R; Telch MJ
    J Consult Clin Psychol; 2006 Dec; 74(6):1203-12. PubMed ID: 17154749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial.
    Powers MB; Smits JA; Telch MJ
    J Consult Clin Psychol; 2004 Jun; 72(3):448-54. PubMed ID: 15279528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of imagery in the maintenance and treatment of snake fear.
    Hunt M; Bylsma L; Brock J; Fenton M; Goldberg A; Miller R; Tran T; Urgelles J
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):283-98. PubMed ID: 16473325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
    Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
    Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific phobias.
    Hamm AO
    Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying.
    Rothbaum BO; Anderson P; Zimand E; Hodges L; Lang D; Wilson J
    Behav Ther; 2006 Mar; 37(1):80-90. PubMed ID: 16942963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy of theoretically derived improvements in the treatment of social phobia.
    Rapee RM; Gaston JE; Abbott MJ
    J Consult Clin Psychol; 2009 Apr; 77(2):317-27. PubMed ID: 19309190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone renders one-session exposure therapy less effective: a controlled pilot study.
    Kozak AT; Spates CR; McChargue DE; Bailey KC; Schneider KL; Liepman MR
    J Anxiety Disord; 2007; 21(1):142-52. PubMed ID: 16647240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.